oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Sunitinib Vipharm

The product does not meet its specified quality requirements due to a negative test result for the appearance parameter; the changed appearance of the capsule filling has not yet been approved in the quality specification. Potential effects: possible concern about medicine quality and a potential risk of dose non-uniformity.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Sunitinib Vipharm
Risk Level
Low
Manufacturer
Vipharm S.A. z siedzibą w Ożarowie Mazowieckim
Batch Number
wszystkie serie (m.in. 4TX01A)
EAN Code
05901812162779
Recall Date
05.06.2025
View official statement

Important Information

What You Should Know

Recommendations

Do not use the product from any batch. Patients who have this medicine should consult their doctor or pharmacist to determine further treatment and possible replacement of the pack.

Actions Taken

Marketing of the medicinal product Sunitinib Vipharm, 25 mg, hard capsules, was suspended throughout the country for all batches and the decision was given immediate enforceability.

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: The product does not meet its specified quality requirements due to a negative test result for the appearance parameter; the changed appearance of the capsule filling has not yet been approved in the quality specification. Potential effects: possible concern about medicine quality and a potential risk of dose non-uniformity.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: wszystkie serie (m.in. 4TX01A)

Related

Other Recalled Products